Donoghue Forlines’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,700
| Closed | -$493K | – | 279 |
|
|
2022
Q1 | $493K | Buy |
6,700
+3,321
| +98% | +$244K | 0.11% | 251 |
|
|
2021
Q4 | $483K | Sell |
3,379
-192
| -5% | -$27.4K | 0.08% | 236 |
|
|
2021
Q3 | $740K | Buy |
3,571
+25
| +0.7% | +$5.18K | 0.14% | 155 |
|
|
2021
Q2 | $753K | Buy |
3,546
+448
| +14% | +$95.1K | 0.14% | 156 |
|
|
2021
Q1 | $562K | Sell |
3,098
-327
| -10% | -$59.3K | 0.11% | 178 |
|
|
2020
Q4 | $382K | Buy |
+3,425
| New | +$382K | 0.07% | 214 |
|